General Information
Drug ID
DR01311
Drug Name
Ombitasvir
Synonyms
2302768XJ8; ABT 267; ABT-267; ABT-267;ABT267;ABT 267; ABT267; CHEBI:85183; CHEMBL3127326; CS-5330; DB09296; Ombitasvir; Ombitasvir (USAN); Ombitasvir [USAN:INN]; Ombitasvir pound>>ABT-267; Ombitasvir(ABT-267); SB16895; SCHEMBL8542284; UNII-2302768XJ8; ZINC150601177; dimethyl ([(2S,5S)-1-(4-tert-butylphenyl)pyrrolidine-2,5-diyl]bis{(4,1-phenylene)carbamoyl(2S)pyrrolidine-2,1-diyl[(2S)-3-methyl-1-oxobutane-1,2-diyl]})biscarbamate
Drug Type
Small molecular drug
Indication Hepatitis C virus infection [ICD11: 1E50.2, 1E51.1] Phase 4 [1]
Therapeutic Class
Antiviral Agent
Structure
3D MOL 2D MOL
Formula
C50H67N7O8
Canonical SMILES
CC(C)C(C(=O)N1CCCC1C(=O)NC2=CC=C(C=C2)C3CCC(N3C4=CC=C(C=C4)C(C)(C)C)C5=CC=C(C=C5)NC(=O)C6CCCN6C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC
InChI
InChI=1S/C50H67N7O8/c1-30(2)42(53-48(62)64-8)46(60)55-28-10-12-40(55)44(58)51-35-20-14-32(15-21-35)38-26-27-39(57(38)37-24-18-34(19-25-37)50(5,6)7)33-16-22-36(23-17-33)52-45(59)41-13-11-29-56(41)47(61)43(31(3)4)54-49(63)65-9/h14-25,30-31,38-43H,10-13,26-29H2,1-9H3,(H,51,58)(H,52,59)(H,53,62)(H,54,63)/t38-,39-,40-,41-,42-,43-/m0/s1
InChIKey
PIDFDZJZLOTZTM-KHVQSSSXSA-N
CAS Number
CAS 1258226-87-7
Pharmaceutical Properties Molecular Weight 894.1 Topological Polar Surface Area 179
Heavy Atom Count 65 Rotatable Bond Count 16
Hydrogen Bond Donor Count 4 Hydrogen Bond Acceptor Count 9
XLogP
7.9
PubChem CID
54767916
ChEBI ID
CHEBI:85183
DT(s) Transporting This Drug P-GP Transporter Info P-glycoprotein 1 Substrate [2]
References
1 ClinicalTrials.gov (NCT03499639) Ombitasvir/ Paritaprevir / Ritonavir Plus Ribavirin in Management HCV and End-stage Kidney Disease
2 Tarascon Pocket Pharmacopoeia 2018 Classic Shirt-Pocket Edition.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.